🔗 Permalink

Inventor profile of:

Stephen Comiskey

City:

Doylestown, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Stephen Comiskey

The entities that hold a legal rights for patent applications filed by inventor Comiskey Stephen:

SYNERGY PHARMACEUTICALS INC. 10 New York, NY United States
BAUSCH HEALTH IRELAND LIMITED 7 Dublin, Ireland

Recent patent applications by Comiskey Stephen

Stephen Comiskey from Doylestown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250171497A1

Chemistry; metallurgy

ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME

#2 | 2025-02-13

US20250049881A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE

#3 | 2024-08-29

US20240287137A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#4 | 2023-10-26

US20230340023A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#5 | 2022-04-21

US20220119449A1

Chemistry; metallurgy

ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME

#6 | 2021-12-30

US20210403508A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#7 | 2021-07-08

US20210205406A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#8 | 2020-12-24

US20200399315A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#9 | 2020-12-10

US20200384068A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#10 | 2020-02-06

US20200040038A1

Chemistry; metallurgy

Process of Preparing Guanylate Cyclase C Agonists

#11 | 2020-01-09

US20200009063A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#12 | 2019-10-24

US20190321439A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#13 | 2019-01-03

US20190002501A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#14 | 2018-07-26

US20180207229A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#15 | 2017-07-20

US20170202904A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#16 | 2017-07-20

US20170202903A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#17 | 2017-05-11

US20170129925A1

Chemistry; metallurgy

Process of preparing guanylate cyclase C agonisys

#18 | 2016-05-26

US20160145307A1

Chemistry; metallurgy

Ultra-pure agonists of guanylate cyclase C, method of making and using same

#19 | 2015-12-24

US20150366935A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#20 | 2015-12-17

US20150359749A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#21 | 2014-06-05

US20140155575A1

Chemistry; metallurgy

Process of preparing guanylate cyclase C agonists

#22 | 2012-09-20

US20120237593A1

Human necessities

Formulations of guanylate cyclase C agonists and methods of use

#23 | 2010-09-02

US20100221329A1

Human necessities

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

InventorID:

788223 ⎘